Results 81 to 90 of about 20,345,278 (297)

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Neuroblastoma (NB) with central nervous system (CNS) metastases is rare at diagnosis, but occurs more often during relapse/progression. Patients with CNS metastases face a dismal prognosis, with no standardized curative treatment available.
Vicente Santa‐Maria Lopez, Anna Felip‐Badia, Marina Caballero‐Bellon, Nazaret Sanchez‐Sierra, Alicia Castañeda, Moira Garraus, Maite Gorostegui, Margarida Simão‐Rafael, Juan Pablo Muñoz, Marta Perez‐Somarriba, Salvador Mañe, Mariana Cecilia Planells, Sara Perez‐Jaume, Jaume Mora   +13 more
wiley   +1 more source

Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Approximately 10% of patients with Ewing sarcoma (EwS) have pathogenic germline variants. Here, we report two cases: first, a novel germline pathogenic variant in partner and localizer of BRCA2 (PALB2) in a patient with a late EwS relapse. Its impact on homologous recombination is demonstrated, and breast cancer risk is discussed.
Molly Mack, A. Carolina Tufino, Mohd Azrin Jamalruddin, Sreya Dey, Yinghong Pan, Elina Mukherjee, Jessica D. Daley, Julia Meade, Mahmoud Aarabi, Lisa Maurer, James Cooper, Kara A. Bernstein, Kelly M. Bailey   +12 more
wiley   +1 more source

Showcasing health psychology postgraduate research: contemporary theory and methods [PDF]

, 2014
This article describes a conference workshop organised by the author which showcased the breadth of current postgraduate research within the area of Health ...
Hill, Kimberley M
core  

Use of mixed methods designs in substance research: a methodological necessity in Nigeria [PDF]

, 2013
The utility of mixed methods (qualitative and quantitative) is becoming increasingly accepted in health sciences, but substance studies are yet to substantially benefit from such utilities.
A Adewuya, A Atkinson, A Bryman, A Bryman, A Bryman, A Dimah, A Klein, A Odenigbo, A Tashakkori, AB Makanjuola, AJ Onwuegbuzie, AO Adewuya, BA Ikuesan, BO Olley, C Teddlie, C Teddlie, CM Woolley, D Freshwater, D Silverman, DA Dawson, DL Morgan, DM Mertens, DT Campbell, E Dumbili, EIC Chikere, Emeka W. Dumbili, EP Stoller, F Measham, FG Castro, FM Moghaddam, GE Abikoye, GE Abikoye, H Wechsler, I Newman, I Obot, J Abdulmalik, J Demant, J Demant, J Wheeldon, J Østergaard, JC Greene, JC Greene, JF Molina-Azorin, JM Morse, JMF Guise, JR Vicary, JW Creswell, JW Creswell, KM Collins, KR Howe, L Brener, LM Coleman, M Denscombe, MG Piacentini, NK Denzin, NL Leech, O Abayomi, OA Odejide, OG Oshodin, OO Umoh, P Bazeley, R Goodwin, RB Johnson, RB Johnson, RB Johnson, RK Yin, S Wemm, TD Jick, VL Plano Clark   +68 more
core   +1 more source

Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post‐Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk Group

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background We describe clinical and biologic characteristics of neuroblastoma in older children, adolescents, and young adults (OCAYA); describe survival outcomes in the post‐immunotherapy era; and identify if there is an age cut‐off that best discriminates outcomes.
Rebecca J. Deyell, Kavitha Srivatsa, Paola Angelini, Pei‐Chi Kao, Brady Payne, Arlene Naranjo, Sveva Castelli, Miho Kato, Miki Ohira, Ulriche Pöetschger, Yaël Mossé, Lucas Moreno, Meredith S. Irwin, Ramya Ramanujachar, Wendy B. London   +14 more
wiley   +1 more source

The reporting of progression criteria in protocols of pilot trials designed to assess the feasibility of main trials is insufficient: a meta-epidemiological study

Pilot and Feasibility Studies, 2019
Introduction Pilot and feasibility trials are conducted to determine feasibility or to collect information that would inform the design of a larger definitive trial.
Lawrence Mbuagbaw, Sarah Daisy Kosa, Daeria O. Lawson, Rosa Stalteri, Oluwatobi R. Olaiya, Ahlam Alotaibi, Lehana Thabane   +6 more
doaj   +1 more source

Patient‐Level Barriers and Facilitators to Inpatient Physical Therapy in Adolescents and Young Adults With a Hematological Malignancy: A Qualitative Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Despite their increased risk for functional impairment resulting from cancer and its treatments, few adolescents and young adults (AYAs) with a hematological malignancy receive the recommended or therapeutic dose of exercise per week during inpatient hospitalizations.
Jennifer A. Kelleher, Jennifer L. Bernstein, Katia M. Crisler, Julia K. Herriott, Kimberly L. Klages, Robin E. Norris, Mariann L. Strenk, Sarah E. Bills, Meghan E. McGrady   +8 more
wiley   +1 more source

Protocol for a systematic review and meta-analysis investigating the impact of continuous versus intermittent enteral feeding in critically ill patients

Systematic Reviews
Introduction Enteral nutrition (EN) is the recommended nutritional support in most critically ill populations. When given by feeding tube, EN may be administered either continuously or intermittently.
Lydia S. Acharya, Anne M. Clayton, Lawrence Mbuagbaw, Simon Oczkowski, Bram Rochwerg, Jennifer Tsang, Kaitryn Campbell, Karin Dearness, Joanna C. Dionne   +8 more
doaj   +1 more source

Psychological Safety Among Interprofessional Pediatric Oncology Teams in Germany: A Nationwide Survey

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Psychological safety (PS) is essential for teamwork, communication, and patient safety in complex healthcare environments. In pediatric oncology, interprofessional collaboration occurs under high emotional and organizational demands. Low PS may increase stress, burnout, and adverse events.
Alexandros Rahn, Anna‐Lena Herbach, Christian Bock, Katharina Fleig, Urs Mücke   +4 more
wiley   +1 more source

A narrative review of norovirus epidemiology, biology, and challenges to vaccine development

npj Vaccines
Norovirus is a leading cause of acute gastroenteritis (AGE) globally. AGE resulting from norovirus causes significant morbidity and mortality in countries of all income levels, particularly among young children and older adults.
Katherine B. Carlson, Anne Dilley, Thomas O’Grady, Jordan A. Johnson, Ben Lopman, Emma Viscidi   +5 more
doaj   +1 more source